Target intelligence / Profile preview

E3 ubiquitin-protein ligase TRIM48 (TRIM48)

Target
TRIM48
Molecular classification
Enzyme, E3 ubiquitin ligase, TRIM (Tripartite motif) protein family
01

Overview

E3 ubiquitin-protein ligase TRIM48 is a member of the tripartite motif (TRIM) protein family, characterized by a RING finger, one or two B-box domains, and a coiled-coil region[1][5][8]. TRIM48 functions as an E3 ubiquitin ligase that promotes K48-linked polyubiquitination and subsequent proteasomal degradation of specific substrates, notably protein arginine methyltransferase 1 (PRMT1)[1][3][8][9]. By targeting PRMT1, TRIM48 facilitates activation of apoptosis signal-regulating kinase 1 (ASK1), increasing oxidative stress-induced cell death, and suppresses FOXO1 transcriptional activity by preventing its methylation[3][8]. In the immune system, TRIM48 acts as a negative feedback regulator of RIG-I-mediated signaling, modulating antiviral responses and interferon production[4]. TRIM48 is implicated in cancer, immune modulation, and possibly other diseases, but no drugs are currently known to directly target it.

Other names
RNF101RING finger protein 101Tripartite motif-containing protein 48TRIM48E3 ubiquitin-protein ligase TRIM48
02

Mechanism of action

Targeting TRIM48 would generally modulate protein ubiquitination pathways, influencing degradation of specific targets such as PRMT1 and pathways like ASK1-mediated apoptosis and antiviral signaling

03

Biological functions

Ubiquitination (promotes K48-linked polyubiquitination of targets)Protein degradation (via proteasome pathway)Regulation of cell death (apoptosis)Innate immune response regulationNegative regulation of RIG-I signaling (innate antiviral immunity)
04

Disease associations

Cancer (promotion of cell death in cancer models)Immune response modulationPotential links to viral infection and immune disorders
05

Safety considerations

Modulating TRIM48 could disrupt normal proteostasis and immune regulation, potentially leading to increased susceptibility to infection or cell death dysregulation

Beyond the preview

Go deeper on E3 ubiquitin-protein ligase TRIM48 (TRIM48).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E3 ubiquitin-protein ligase TRIM48 (TRIM48).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call